BST News and Press, BlackRock Science and Technology Trust of Beneficial Interest From 08/18/20

Written by Nick Ackerman, co-produced by Stanford Chemist July was another solid month for the market as measured by the S&P 500 ETF ( SPY ), a barometer for the overall market. This is, of course, a continuation of the rebound from March's lows. Interestingly enough, for the month o...

Closed-End Funds (CEFs) are great tool now to squeeze high payouts from high-growth stocks, like Apple (AAPL), that pay little or no dividends. I know that sounds a little off the wall, but I assure you it’s true. Better still, we get the same price upside we’d have gotten by purc...

Written by Nick Ackerman, co-produced by Stanford Chemist Recently, we took a position in BlackRock Science & Technology Trust II ( BSTZ ). This was in our Tactical Income-100 Portfolio. This portfolio is designed to be more aggressive and take advantage of special situations. In t...

Written by Nick Ackerman, co-produced by Stanford Chemist Columbia Seligman Premium Technology Growth Fund ( STK ) is another interesting tech fund similar to BlackRock's Science and Technology Trust ( BST ). STK hasn't performed nearly as well as BlackRock's tech offerings. However, the...

I could probably go on and on about why the BlackRock Science & Technology II fund ( BSTZ ) , $23.95 current market price, $27.34 NAV, -12.4% discount, 5.0% current market yield , is still a big fat opportunity even after writing this article, Equity CEFs: A Big Fat Opportunity In...

The broader market continues to defy gravity in the face of a spike in COVID-19 cases in many states. This has caused many states to halt or slow down their plans to reopen the economy fully. But in spite of the spike, there are positive signs, and we are learning to deal with the virus more...

Written by Nick Ackerman, co-produced by Stanford Chemist The first half of 2020 had come in with a bang, and the market quickly hit all-time highs on February 19th. This was even as COVID-19 was beginning to spread around the globe. After reaching those all-time highs, the market quickl...

Written by Nick Ackerman, co-produced by Stanford Chemist In the closed-end fund world, there are plenty of fund sponsors offering funds worthy of investing. Investors looking at getting started with CEFs may be interested in knowing where to get started. One of the first steps that can ...

Written by Nick Ackerman, co-produced by Stanford Chemist Continuing with our coverage of BlackRock funds, as we had done with Eaton Vance's funds, we will be focusing on BlackRock's sector-focused funds. In today's piece, we will be looking at the healthcare and tech names offered by Bl...

The market is currently near-maximum greed levels. The tech sector is seeing this more so than other sectors, and, in this sector, we are seeing RSI levels similar to those during the dot-com bubble. Optimism in tech is higher than ever in history, with the exception of the peak of the 2000 te...